ArticleScientific reports2025
Oral administration of antimicrobial peptide MPX can effectively regulate LPS-mediated testicular oxidative stress and blood‒testis barrier damage.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Article
- Probiotics as Microbiome Modulators in Male Infertility: Rethinking Dysbiosis Across the Gut-Testis Axis.Journal of personalized medicine · 2026Review
- Effect of supplementation with different dietary energy sources on semen quality in a cold-stressed boar model.Animal biotechnology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
Abstract
Oxidative stress and disruption of blood‒testis barrier permeability are considered key factors in the pathogenesis of testicular inflammation, degeneration, and functional impairment, which play crucial roles in male infertility. Antimicrobial peptides (AMPs) are internationally recognized as some of the most promising alternatives to antibiotics. However, the molecular mechanisms by which AMPs regulate oxidative stress and the blood‒testis barrier in the testis are still poorly understood. In this study, we orally administered 0.5 mg/kg antimicrobial peptide MPX (MPX) to mice for 20 and 40 days and evaluated its effects on Lipopolysaccharide LPS-induced testicular oxidative stress and blood‒testis barrier repair, and elucidateed the pharmacokinetics of MPX in mice. The experiment was divided into six groups, control, LPS, MPX, MPX + LPS, Polymyxin and Polymyxin + LPS, respectively. The results showed that oral administration of MPX effectively increased testicular Glutathione (GSH), Total superoxide dismutase (T-SOD), and Catalase (CAT) levels and reduced Nitric oxide (NO) and Malondialdehyde (MDA) levels in the testes and Lactate dehydrogenase (LDH) levels in serum; these findings were consistent with the oxidative stress parameters in the liver. MPX significantly upregulated the expression of Kelch-like ECH-associated protein 1 (Keap1), Nuclear factor erythroid 2-related factor 2 (Nrf2), and Glutamate cysteine ligase, modifier (GLCM) in the testes while downregulating the expression of Glutamate cysteine ligase, catalytic (GCLC) and Inducible nitric oxide synthase (iNOS), thus exerting a regulatory effect on oxidative stress. MPX also effectively increased sperm count and motility and counteracted the LPS-induced blood‒testis barrier damage, and its molecular mechanism involved upregulating the expression of Slug, which subsequently promoted high expression of Claudin, Occludin, Zonula occludens-1 (ZO-1), N-cadherin, and E-cadherin in the testes. After intragastric administration of FITC-MPX for 30 min, FITC-MPX was mainly distributed in the stomach and thoracic cavity, then showed multi-tissue distribution after 30 min. The fluorescence signal could be detected in the testis 1 h later, which confirmed that MPX had testicular targeting. Moreover, both intraperitoneal and intravenous injection of FITC-MPX also confirmed its testicular targeting ability. In conclusion, this study systematically evaluated the long-term effects of the orally administered antimicrobial peptide MPX on oxidative stress and the blood‒testis barrier in the male reproductive system. This study laid the foundation for the antimicrobial peptide MPX to be used in the treatment of male testicular inflammatory diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.